THE EFFECT OF AGE ON OUTCOME OF SYNOVIAL SARCOMA PATIENTS A DUTCH POPULATION BASED STUDY Myrella Vlenterie, SEJ Kaal, VKY Ho, R Vlenterie, WTA van der.

Slides:

Advertisements

Similar presentations

High Resolution data for rare cancers Annalisa Trama Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy ) WORKSHOP FOR A EUROPEAN HIGH RESOLUTION.

Advertisements

1 Januari 2014 Via Beeld| Koptekst en voettekst kunt u deze tekst wijzigenVia Beeld| Koptekst en voettekst kunt u deze tekst wijzigen 1 Workflow of the.

Neoadjuvant Chemotherapy in Malignant Peripheral Nerve Sheath Tumors Elizabeth Shurell, M.D., M.Phil. UCLA General Surgery Resident Research Fellow, Division.

CLINICAL CHARACTERISTICS AND OUTCOMES FOR BENIGN AND MALIGNANT SOLITARY FIBROUS TUMOR / HEMANGIOPERICYTOMA (SFT/HPC) – A SINGLE CENTER EXPERIENCE Nicholas.

Primary thoracic sarcomas: prognostic factors and outcome in a series of patients treated at a single institution Leonardo Duranti T horacic Surgery.

Value of local treatment in extrapulmonary metastatic Ewing sarcoma

IMPACT OF CHEMOTHERAPY IN UTERINE SARCOMA (UTS): REVIEW OF 12 CLINICAL TRIALS FROM EORTC INVOLVING ADVANCED UTS COMPARED TO OTHER SOFT TISSUE SARCOMA (STS)

Impact of the Type and Modalities of Preoperative Chemotherapy on the Outcome of Liver Resection for Colorectal Metastases R. Adam, E. Barroso, C. Laurent,

Modified Megestrol The Clinical Trials by : Carolina R. Akib

Janet Eary 1, Janet O'Sullivan 3, Finbarr O'Sullivan 3, E. U. Conrad 2 1. Nuclear Medicine/Radiology, University of Washington, Seattle, WA, United States.

Clinicopathologic Characteristics and Predictors of Outcomes in Patients with Primary Retroperitoneal Dedifferentiated Liposarcoma Undergoing Surgery Emily.

Departments - Surgery - Gerontology and Geriatrics Department of SurgeryDepartment of Gerontology & Geriatrics Prof. dr. C.J.H. van de VeldeProf. dr. R.G.J.

Analysis of risk factors predicting time to development of brain metastases presented at the 44 th Annual ASCO Meeting, June , McCormick.

Synovial sarcoma- which patients don’t need adjuvant treatment? Khan M, Rankin KS, Beckingsale TB, Todd R, Gerrand CH North of England Bone and Soft Tissue.

Prognostic factors for breast cancer survival in affluent and deprived areas Jasmina Stefoski-Mikeljevic.

THE SIGNIFICANCE OF HISTOLOGICAL SUBSTAGING IN CURATIVE RESECTED T3 COLORECTAL CANCER Karl Mrak & Jörg Tschmelitsch Department of Surgery, Barmherzige.

Kerrington Smith, M.D. CTOS Nov 14, 2008

Skull Base Chordoma and Chondrosarcoma: Changes in National Radiotherapy Patterns and Survival Outcomes Henry S. Park, MD, MPH; Kenneth B. Roberts, MD;

SPINDLE CELL SARCOMA OF BONE AN ASSESSMENT OF OUTCOME

Multimodality therapy for locally advanced thymomas: a cohort study of prognostic factors from a European multicentric database Dr. GIOVANNI LEUZZI Department.

Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,

Background  Reports of long-term survivors (≥5 years) of locally advanced esophageal cancer (LAEC) have focused mainly on HRQL or GI symptoms  Only.

HCI Sarcoma Services Sequential Dependency of Radiotherapy for Soft-Tissue Sarcoma S Sampath TE Schultheiss YJ Hitchcock RL Randall DC Shrieve JYC Wong.

Conclusion IS SECOND LINE SYSTEMIC CHEMOTHERAPY BENEFICIAL IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)? : A MULTICENTER DATA EVALUATION (ANATOLIAN.

Clinical variables, pathological factors, and molecular markers for enhanced soft tissue sarcoma prognostication G. Lahat, B. Wang, D. Tuvin, DA. Anaya,

Outcome of chemotherapy in synovial sarcoma (sys) patients (pts): review of 15 clinical trials from EORTCc involving advanced sys compared to other Soft.

Ductal Carcinoma in Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary Evaluation Rahul R. Parikh, MD 1, Bruce.

Per-Ulf Tunn, D. Andreou, S. Fehlberg, M. Werner, P. Reichardt

Evidence for a Survival Benefit Conferred by Adjuvant Radiotherapy in a Cohort of 608 Women with Early-stage Endometrial Cancer O. Kenneth Macdonald 1,

Vivianne Tjan-Heijnen, MJ Pepels, M de Boer, GF Borm, JA van Dijck, CH van Deurzen, EM Adang, MB Menke- Pluymers, PJ van Diest and P Bult On behalf of.

LOCAL CONTROL MODALITY AND OUTCOME IN EWING SARCOMA OF THE FEMUR: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP Najat C. Daw, Nadia N. Laack, Elizabeth J.

Malignancy Grade and Histologic Subtype of Primary Retroperitoneal Sarcoma (RPS) are Predictive of Pattern of Recurrence: a Large Retrospective Study from.

Therapeutic Delay and Survival after Surgery for Cancer of the Pancreatic Head with or without Preoperative Biliary Drainage Eshuis, van der Gaag, Rauws.

Role of Sentinel Lymph Node Biopsy in the Staging of Synovial, Epithelioid, and Clear Cell Sarcomas. Ugwuji N. Maduekwe, Francis J. Hornicek, Dempsey S.

Local Recurrence Growth Rate Predicts Outcome In Locally Recurrent Retroperitoneal Liposarcoma James Park, MD, Li-Xuan Qin, PhD, Francesco Prete, MD Murray.

National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.

Patterns of Care and Prognosis of Retroperitoneal Sarcomas in the Primary and Advanced Settings A Large Multicentric Retrospective Analysis from the French.

Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.

Pt ZJ 19yo M that presented to Seattle Children’s for evaluation of 3 lesions found on recent PET CT ◦ One large mass in the posterior mediastinum just.

What Factors Predict Outcome At Relapse After Previous Esophagectomy And Adjuvant Therapy in High-Risk Esophageal Cancer? Edward Yu 1, Patricia Tai 5,

Sex-specific trends in lung cancer incidence and survival : a population study of cases 호흡기 내과 R3 조주희 Thorax 2011;66: Camilla M T Sagerup,

Evaluating the Clinical Outcomes of Sixty-Three Patients Treated with Gamma Knife as Salvage Therapy for Glioblastoma Multiforme Erik W Larson, Halloran.

Image Guided Interstitial Brachytherapy For Locally Advanced Gynaecological Cancer With A MUPIT Applicator M.A.D. Haverkort, MD 1, E. Van der Steen - Banasik,

Lung Cancer in Never-Smokers from the Princess Margaret Cancer Centre 1 Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada;

Accelerated radical radiotherapy for Non Small Cell Lung Cancer: Single centre audit outcome of two fractionations in the treatment of the elderly patients.

Improved survival in primary central nervous system lymphoma up to age 70: a population-based study on incidence, primary treatment and survival in the.

Prognostic significance of tumor subtypes in male breast cancer:

Results of Definitive Radiotherapy in Anal Canal Carcinoma

Aspirin Associated With Reduced Mortality in Patients With CRC CCO Independent Conference Highlights of the 2015 ASCO Annual Meeting* May 29 - June 2,

Clinicopathological features and outcome of Head & Neck Cancer in Pakistan 1A Jamshed, 1R Hussain, 2S Jamshed, 1A A Syed, 1A Loya, 1M A Shah, 1U Majeed.

Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.

Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: Influence of Prognostic Factors of Survival J Tabernero,

Director Department of Pediatric Hematology & Oncology Delhi, INDIA.

Discordance of histo-pathological diagnosis of patients with soft tissue sarcoma referred to tertiary care center. Rastogi,S., Aggarwal, A., Soti, K.,

Concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after chemoradiation: outcome and survival S.T. Heijkoop1,2; H.C. van.

Prognosis of younger patients in non-small cell lung cancer

Laparoscopic vs Open Colonic Surgery: Long Term Survival

A Paradigm Shift From One-Size-Fits-All to Tailor-Made Therapy for Metastatic Colorectal Cancer.

Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.

Published online September 20, 2017 by JAMA Surgery

• Kaplan-Meier analyses of (A) overall survival (OS) of the whole cohort (n=173), (B) OS from time of diagnosis of high-risk melanoma among those who remained.

PRIMARY EXTREMITY STS: MULTIMODAL APPROACH MAY HAVE IMPROVED SURVIVAL

Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer. A meta-analysis of two randomized trials E Mitry, A Fields,

Treated with Neoadjuvant Therapy

GOCS GRUPO ONCOLÓGICO COOPERATIVO DEL SUR

NAACCR/IACR Combined Annual Conference 2019

The SUV on 18F-FDG-PET/CT imaging as an independent predictor for overall survival and disease free survival after hepatectomy of Hepatocellular carcinoma（

Fig. 1. Classification of the Kaplan-Meier curves and Cox survival estimates for the OS of patients using the pSPC in Cohort_C and in the overall population.

Surgical resection of metachronous liver metastases

Volume 20, Issue 8, Pages (August 2019)

Presentation transcript:

THE EFFECT OF AGE ON OUTCOME OF SYNOVIAL SARCOMA PATIENTS A DUTCH POPULATION BASED STUDY Myrella Vlenterie, SEJ Kaal, VKY Ho, R Vlenterie, WTA van der Graaf Medical Oncology, Radboud University Medical Centre, Nijmegen

Literature

Research question Is age an independent prognostic factor for overall and relative survival in synovial sarcoma patients?

Research question Is age an independent prognostic factor for overall and relative survival in synovial sarcoma patients? Do treatment modalities explain the differences between variant age groups?

Materials & Methods The Netherlands Cancer Registry: >95% coverage Information at diagnosis Tumour and patient characteristics, diagnostics and therapy Sources: Dutch pathology network (PALGA) & hospital records

Materials & Methods The Netherlands Cancer Registry: >95% coverage Information at diagnosis Tumour and patient characteristics, diagnostics and therapy Sources: Dutch pathology network (PALGA) & hospital records Cancer care in the Netherlands Sarcoma care centralised in recent years

Materials & Methods The Netherlands Cancer Registry: >95% coverage Information at diagnosis Tumour and patient characteristics, diagnostics and therapy Sources: Dutch pathology network (PALGA) & hospital records Cancer care in the Netherlands Sarcoma care centralised in recent years Statistics: Kaplan Meier for Overall survival (OS) Relative survival (RS) Univariate analyses Multivariate Cox regression analyses

Age groups Children < 18years Adults 35-64years AYAs 18-34years Elderly ≥65years

Patient cohort Total: 586 patients

Overall survival: stage at diagnosis No metastasis 5yr OS: 64±2% Unknown stage Metastases median survival: 11±1months Median follow up: 42 months (range months) Cumulative survival Survival time (months)

Localised disease

Patient characteristics Variablen = 438(100%) Age o <18 years o years o years o ≥65 years (12%) (33%) (44%) (12%) Sex o Male o Female (54%) (46%) Histology o Monophasic o Biphasic o Not specified (22%) (56%) Hospital of surgery o General hospital o Academic hospital o Unknown (25%) (45%) (31%)

Patient characteristics Variablen = 438(100%) Site of origin o Extremities o Head and neck o Trunk o Other (67%) (8%) (18%) (7%) Therapy o Surgery alone o Surgery + RT (+CT) o Surgery + CT o No surgery (35%) (47%) (9%) (10%) Resection status o R0 o R1 / R2 o R status unknown (31%) (12%) (58%)

Overall survival: age groups 5yr OS: 91±4% Children 5yr OS: 72±4% AYAs 5yr OS: 57±4% Adults 5yr OS: 43±7% Elderly Cumulative survival Survival time (months)

Relative survival: age groups 5yr OS: 91% 5yr RS: 91%Children 5yr OS: 72% 5yr RS: 72%AYAs 5yr OS: 57% 5yr RS: 58%Adults 5yr OS: 43% 5yr RS: 53%Elderly RS: Corrected for age, sex and year

Age as a continous variable Age (years) Survival time (months)

Cox regression: Univariate analyses

p < 0.10

Cox regression: Univariate analyses p < 0.10

Cox regression: Univariate analyses p < 0.10

Treatment modalities *Chi-square: p<0.05 * 43 patients received no surgery  left out of multivariate analysis

Cox regression: Multivariate analysis

Take home messages 1.Age at diagnosis is an independent prognostic factor for overall and relative survival 2.Survival differences can not be explained by treatment modalities

Future research Further research in tumor biology is necessary to explain the survival differences